138 related articles for article (PubMed ID: 38724670)
1. Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells.
Li J; Cao Q; Tong M
Sci Rep; 2024 May; 14(1):12044. PubMed ID: 38802480
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of enhancer RNA AC003092.1 is associated with poor prognosis in kidney renal clear cell carcinoma.
Li J; Gan J; Chen C; Yuan Y; Xiong X; Li L; Luo P; Zhang W
Sci Rep; 2024 Jun; 14(1):13475. PubMed ID: 38866983
[TBL] [Abstract][Full Text] [Related]
3. Spatial Transcriptomics in a Case of Follicular Thyroid Carcinoma Reveals Clone-Specific Dysregulation of Genes Regulating Extracellular Matrix in the Invading Front.
Condello V; Paulsson JO; Zedenius J; Näsman A; Juhlin CC
Endocr Pathol; 2024 Jun; 35(2):122-133. PubMed ID: 38280140
[TBL] [Abstract][Full Text] [Related]
4. Differential expression analysis identifies a prognostically significant extracellular matrix-enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma.
Jokelainen O; Rintala TJ; Fortino V; Pasonen-Seppänen S; Sironen R; Nykopp TK
Sci Rep; 2024 May; 14(1):10626. PubMed ID: 38724670
[TBL] [Abstract][Full Text] [Related]
5. SRplot: A free online platform for data visualization and graphing.
Tang D; Chen M; Huang X; Zhang G; Zeng L; Zhang G; Wu S; Wang Y
PLoS One; 2023; 18(11):e0294236. PubMed ID: 37943830
[TBL] [Abstract][Full Text] [Related]
6. TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity.
Narita T; Tobisawa Y; Bobkov A; Jackson M; Ohyama C; Irie F; Yamaguchi Y
J Biol Chem; 2023 Sep; 299(9):105120. PubMed ID: 37527776
[TBL] [Abstract][Full Text] [Related]
7. Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.
Lasorsa F; Rutigliano M; Milella M; Ferro M; Pandolfo SD; Crocetto F; Tataru OS; Autorino R; Battaglia M; Ditonno P; Lucarelli G
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373581
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies.
Schiavoni V; Campagna R; Pozzi V; Cecati M; Milanese G; Sartini D; Salvolini E; Galosi AB; Emanuelli M
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370817
[TBL] [Abstract][Full Text] [Related]
9. Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma.
Goodstein T; Yang Y; Runcie K; Srinivasan R; Singer EA
Curr Opin Oncol; 2023 May; 35(3):206-217. PubMed ID: 37226958
[TBL] [Abstract][Full Text] [Related]
10. The role of hyaluronan in renal cell carcinoma.
Jin C; Zong Y
Front Immunol; 2023; 14():1127828. PubMed ID: 36936902
[TBL] [Abstract][Full Text] [Related]
11. The Gene Ontology knowledgebase in 2023.
; Aleksander SA; Balhoff J; Carbon S; Cherry JM; Drabkin HJ; Ebert D; Feuermann M; Gaudet P; Harris NL; Hill DP; Lee R; Mi H; Moxon S; Mungall CJ; Muruganugan A; Mushayahama T; Sternberg PW; Thomas PD; Van Auken K; Ramsey J; Siegele DA; Chisholm RL; Fey P; Aspromonte MC; Nugnes MV; Quaglia F; Tosatto S; Giglio M; Nadendla S; Antonazzo G; Attrill H; Dos Santos G; Marygold S; Strelets V; Tabone CJ; Thurmond J; Zhou P; Ahmed SH; Asanitthong P; Luna Buitrago D; Erdol MN; Gage MC; Ali Kadhum M; Li KYC; Long M; Michalak A; Pesala A; Pritazahra A; Saverimuttu SCC; Su R; Thurlow KE; Lovering RC; Logie C; Oliferenko S; Blake J; Christie K; Corbani L; Dolan ME; Drabkin HJ; Hill DP; Ni L; Sitnikov D; Smith C; Cuzick A; Seager J; Cooper L; Elser J; Jaiswal P; Gupta P; Jaiswal P; Naithani S; Lera-Ramirez M; Rutherford K; Wood V; De Pons JL; Dwinell MR; Hayman GT; Kaldunski ML; Kwitek AE; Laulederkind SJF; Tutaj MA; Vedi M; Wang SJ; D'Eustachio P; Aimo L; Axelsen K; Bridge A; Hyka-Nouspikel N; Morgat A; Aleksander SA; Cherry JM; Engel SR; Karra K; Miyasato SR; Nash RS; Skrzypek MS; Weng S; Wong ED; Bakker E; Berardini TZ; Reiser L; Auchincloss A; Axelsen K; Argoud-Puy G; Blatter MC; Boutet E; Breuza L; Bridge A; Casals-Casas C; Coudert E; Estreicher A; Livia Famiglietti M; Feuermann M; Gos A; Gruaz-Gumowski N; Hulo C; Hyka-Nouspikel N; Jungo F; Le Mercier P; Lieberherr D; Masson P; Morgat A; Pedruzzi I; Pourcel L; Poux S; Rivoire C; Sundaram S; Bateman A; Bowler-Barnett E; Bye-A-Jee H; Denny P; Ignatchenko A; Ishtiaq R; Lock A; Lussi Y; Magrane M; Martin MJ; Orchard S; Raposo P; Speretta E; Tyagi N; Warner K; Zaru R; Diehl AD; Lee R; Chan J; Diamantakis S; Raciti D; Zarowiecki M; Fisher M; James-Zorn C; Ponferrada V; Zorn A; Ramachandran S; Ruzicka L; Westerfield M
Genetics; 2023 May; 224(1):. PubMed ID: 36866529
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan in the Cancer Cells Microenvironment.
Karousou E; Parnigoni A; Moretto P; Passi A; Viola M; Vigetti D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765756
[TBL] [Abstract][Full Text] [Related]
13. What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R; Siadat F; Trpkov K
Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
[TBL] [Abstract][Full Text] [Related]
14. Theranostic Applications of Glycosaminoglycans in Metastatic Renal Cell Carcinoma.
Hua SH; Viera M; Yip GW; Bay BH
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612261
[TBL] [Abstract][Full Text] [Related]
15. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of the Role of Enolase 2 in Clear Cell Renal Cell Carcinoma.
Pan J; Jin Y; Xu X; Wei W; Pan H
Dis Markers; 2022; 2022():6539203. PubMed ID: 36419844
[TBL] [Abstract][Full Text] [Related]
17. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.
Szklarczyk D; Kirsch R; Koutrouli M; Nastou K; Mehryary F; Hachilif R; Gable AL; Fang T; Doncheva NT; Pyysalo S; Bork P; Jensen LJ; von Mering C
Nucleic Acids Res; 2023 Jan; 51(D1):D638-D646. PubMed ID: 36370105
[TBL] [Abstract][Full Text] [Related]
18. KEGG for taxonomy-based analysis of pathways and genomes.
Kanehisa M; Furumichi M; Sato Y; Kawashima M; Ishiguro-Watanabe M
Nucleic Acids Res; 2023 Jan; 51(D1):D587-D592. PubMed ID: 36300620
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
